openPR Logo
Press release

Transdermal Drug Delivery Systems Market – Trends 2025

09-28-2017 03:22 PM CET | Health & Medicine

Press release from: Pharamceutical

Transdermal Drug Delivery Systems Market

Transdermal Drug Delivery Systems Market

A transdermal drug delivery systems (TDDS) is a medicated adhesive bandage or a patch that is stuck onto the skin to deliver a dose of drug through the skin and in the bloodstream. This patch promotes faster healing of injuries on the body, delivers a steady infusion of the drug over a time period and increases the therapeutic value of drugs by avoiding problem associated with drug. This is a simple technique in which the patch is placed on the injured part of body, from where the drug slowly penetrates in to the skin and it heals the injured part.
The advantages of transdermal drug delivery system are  - it is non-invasive, less painful to the patient,administration of complete dose , provides controlled plasma level of the potent drugs, termination of therapy is easy at any time if not necessary, it is a cost effective treatment and the bandage or patch is removable. The main components of TDDS are liner, drug, adhesive, membrane, blacking, matrix filler, and permeation enhancer. The types of TDDS includes single layer drug in adhesive, multi-layer drug in adhesive, reservoir, vapor and matrix.
The technological advancement in transdermal drug delivery system is anticipated to serve the market growth in the near future. The advance technology includes transdermal patch design modification, incorporation of pressure sensitive adhesives and permeation enhancers that results in the enhancement of drug diffusion and increased the capacity to hold the drug in excess amount.

Request a sample copy of this report@

Transdermal drug delivery systems market taxonomy
Transdermal Drug Delivery Systems Market by Application:
Neurological Disorders Pain Management,Hormone Replacement Therapy,Cardiovascular,Smoking Cessation,Contraception,Others
Transdermal Drug Delivery Systems Market by Technology:
Electroporation,Electric current,Lontophoresis,Radio Frequency,Microporation,Thermal,Mechanical arrays,Ultrasound,Others
Transdermal Drug Delivery Systems Market by Geography:
North America,Latin America,Europe,Asia Pacific,Middle East,Africa
Rise in number of surgical procedures around the globe and increase in prevalence of cardiovascular disorders is expected to further bolster the transdermal drug delivery system market growth
North America and Asia Pacific are expected to lead the highest growth in transdermal drug delivery system market due to the rise in emergency medical cases and the increase of surgical procedures. As per the World Health Organization (WHO), the global surgical volume in 2012 was around 312.9 million. The cardiovascular disorders are expected to grow at an exponential stage during the forecast period,  that  can be attributed to increase the  utilization of transdermal drug delivery systems. According to the American Heart Association, it was estimated that the incident of heart attack in the U.S. was around 58000 in 2014, and in 2013 worldwide prevalence of stroke was around 25.7 million. Also as per the World Health Organization (WHO), it was estimated that in 2015, around 17.7 million people died from cardiovascular diseases (CVDs) including around 31% of global deaths and among this, around 7.4% had coronary heart disease.
The growth in various type of diseases such as skin ulcer, acne and skin rash leads the exponential growth of surgical procedures and hence, this surgeries growth can be attributed to increase in utilization of transdermal drug delivery systems. As per World Health Organization (WHO), the global surgical volume in 2012 was around 312.9 million, as the estimated mean global surgical rate was 4469 operations per 100 000 people every year.
Transdermal Drug Delivery Systems Market by Key Player Includes:
Therapeutics Inc., ALLERGAN, Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co.Inc., IBSA Institut Biochimque SA, Mylan N.V. , Pfizer, Inc., TEH SENG Pharmaceutical Mfg. Co., Ltd., and Teikoku Seiyaku Co., Ltd., 3M Pharmaceuticals Inc., Actelion Pharmaceuticals Ltd, Bayer Crop Science Ltd., BioGel Technology Inc., Upsher-Smith Laboratories, Inc., Johnson & Johnson Limited, Mylan Pharmaceuticals Inc., Novartis AG, Janssen Pharmaceuticals, Inc., Noven Pharmaceuticals Inc., Boehringer Ingelheim GmbH and Actavis Inc.

Get Discount on this Report@

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transdermal Drug Delivery Systems Market – Trends 2025 here

News-ID: 746659 • Views: 272

More Releases from Pharamceutical

Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast

All 5 Releases

More Releases for Transdermal

Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
US Transdermal Patch Market Outlook 2020 Report
“US Transdermal Patch Market Outlook 2020” Report Highlights: * US Transdermal Patch Market Overview * Generic & Branded Transdermal Patches * US Transdermal Patch Market: Value Chain Analysis * US Transdermal Patch Contract Manufacturing Organization * US Transdermal Patch Clinical Pipeline Insight by Company, Indication & Phase * US Transdermal Patch Clinical Pipeline: 55 Patches * Majority Patches in Preclinical Phase: 23 Patches * Marketed Transdermal Patch Clinical Insight by Company & Indication * Marketed Transdermal Patches in
Therapeutic Landscape of Transdermal Drug Delivery Pipeline
Summary The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products. GET SAMPLE REPORT @ Scope -
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
Global Transdermal Absorption Patch Market Research Report
Latest industry research report on: Global Transdermal Absorption Patch Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Transdermal Absorption Patch industry. Complete Report Details @ This report splits
Transdermal Drug Delivery System Market 2017 -
Apex Research, recently published a detailed market research study focused on the "Transdermal Drug Delivery System Market" across the global, regional and country level. The report provides 360° analysis of "Transdermal Drug Delivery System Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Transdermal Drug Delivery System industry, and estimates the future